HHS to purchase Moderna omicron-specific COVID-19 vaccine booster

The Department of Health and Human Services has agreed to purchase 66 million doses of Moderna’s omicron-specific COVID-19 vaccine booster for use this fall if authorized by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention. HHS similarly agreed to purchase at least 105 million doses of Pfizer’s omicron-specific vaccine last month. Both the Moderna and Pfizer agreements include the option to purchase up to 300 million doses from each company, which would require additional funding from Congress.
Related News Articles
Headline
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament…
Headline
The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months…
Headline
Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2…
Headline
AHA is offering for hospitals and health systems a second social media toolkit for February with messages for promoting COVID-19 vaccination and boosters. The…
Headline
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing…
Headline
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated…